Clinical Trial

Evaluation of the Effect of Smoking on Pyroptosis in Periodontal Pathogenesis

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study investigates the impact of smoking on pyroptosis and inflammatory signaling pathways in systemically healthy individuals with various periodontal conditions. The research compares smokers and non-smokers across three clinical categories, resulting in six study groups: Healthy Control, Gingivitis, and Periodontitis. The study specifically evaluates the levels of IL-1beta, IL-18, and NLRP3 through ELISA, and the gene expression of TLR1, TLR4, and TLR6 through RT-PCR, to understand how cigarette smoke modulates innate immune responses in the absence of other systemic diseases.
Trial Details
NCT Number NCT07563192
Lead Sponsor Suleyman Demirel University
Conditions Periodontitis, Gingivitis, Periodontal Diseases, Smoking ( Cigarette)
Enrollment 113 participants
Start Date 2024-10-15
Primary Completion 2025-11-18 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-01